ReviewAAPS PharmSciTech2015

Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements.

K K Pulicherla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.